BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28639030)

  • 41. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.
    Karasawa K; Kunogi H; Hirai T; Hojo H; Hirowatari H; Izawa H; Ito K; Sasai K; Kawashima M; Furuya T; Sugimoto S; Kurokawa C; Ozawa S; Saito M
    Breast Cancer; 2014 Jul; 21(4):402-8. PubMed ID: 22968629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of Care and Utilization of Radiation for Women With Good-Risk Ductal Carcinoma In Situ: A National Cancer Database Analysis.
    Silver B; Mattessich S; Yacoub I; Rhee B; Schreiber D
    Cureus; 2022 Aug; 14(8):e28223. PubMed ID: 36158412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy.
    Isfahanian N; Al-Hajri T; Marginean H; Chang L; Caudrelier JM
    Clin Breast Cancer; 2017 Apr; 17(2):e77-e85. PubMed ID: 27889437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
    Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in Use of Hypofractionated Whole Breast Radiation in Breast Cancer: An Analysis of the National Cancer Database.
    Woodward SG; Varshney K; Anne PR; George BJ; Willis AI
    Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):449-457. PubMed ID: 32931866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased use of partial-breast irradiation has not improved radiotherapy utilization for early-stage breast cancer.
    Billar JA; Sim MS; Chung M
    Ann Surg Oncol; 2014 Dec; 21(13):4144-51. PubMed ID: 24969442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
    Sayan M; Vergalasova I; Jhawar S; Kumar S; George M; Kowzun M; Potdevin L; Toppmeyer D; Haffty B; Ohri N
    Clin Breast Cancer; 2021 Feb; 21(1):31-36. PubMed ID: 32792224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database.
    Killelea BK; Yang VQ; Mougalian S; Horowitz NR; Pusztai L; Chagpar AB; Lannin DR
    J Am Coll Surg; 2015 Jun; 220(6):1063-9. PubMed ID: 25868410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of care for omission of radiation therapy for elderly women with early-stage breast cancer receiving hormonal therapy.
    Rhieu BH; Rajagopalan MS; Sukumvanich P; Kelley JL; Ahrendt GM; Heron DE; Beriwal S
    Pract Radiat Oncol; 2015; 5(4):e267-73. PubMed ID: 25620165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma.
    Gin GE; Ruel NH; Kardos SV; Sfakianos JP; Uchio E; Lau CS; Yuh BE
    Urol Oncol; 2017 May; 35(5):192-200. PubMed ID: 28041996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy.
    Rudat V; Nour A; Ghaida SA; Alaradi A
    Radiat Oncol; 2016 Jul; 11():100. PubMed ID: 27473272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypofractionated radiation therapy for breast cancer: long-term results in a series of 85 patients.
    Deantonio L; Cozzi S; Tunesi S; Brambilla M; Masini L; Pisani C; Gambaro G; Magnani C; Krengli M
    Tumori; 2016 Aug; 102(4):398-403. PubMed ID: 27230276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypofractionated radiation therapy versus conventionally fractionated radiation therapy for early-stage breast cancer: how do we choose?
    Evans SB; Yu JB
    Future Oncol; 2015; 11(15):2105-7. PubMed ID: 26235175
    [No Abstract]   [Full Text] [Related]  

  • 58. A comparison of timely completion of hypofractionated and traditional adjuvant radiation therapy in early-stage breast cancer: Evidence of impact on reducing racial and socioeconomic disparities.
    Lamm R; Woodward SG; Varshney K; Lyons W; Anne PR; George BJ; Willis AI
    Surgery; 2022 Jul; 172(1):31-40. PubMed ID: 35489980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis.
    Stokes WA; Kavanagh BD; Raben D; Pugh TJ
    Pract Radiat Oncol; 2017; 7(4):270-278. PubMed ID: 28673554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.
    Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.